Open Access Article
Article

Hematologic Effects

Gail B. Johnson

Kimberly Quiett

hematopoietic cell transplantation, neutropenia, immunosuppression, thrombocytopenia, risk factors
CJON 2007, 11(1), 138-150. DOI: 10.1188/07.CJON.138-150

This excerpt, chapter 7 from the book Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice, edited by Susan A. Ezzone, MS, RN, CNP, is part of a series of clinically relevant reprints that appear regularly in the Clinical Journal of Oncology Nursing.

Jump to a section

    References

    Alcoser, P.W., & Burchett, S. (1999). Bone marrow transplantation: Immune system suppression and reconstitution. American Journal of Nursing, 99, 26-32.
    American Society of Clinical Oncology. (1996). Guidelines for use of CSFs as adjuncts to progenitor cell transplants. Journal of Clinical Oncology, 14, 1957-1960.
    Anderson, D., DeFor, T., Burns, L., McGlave, P., Miller, J., Wagner, J., et al. (2003). A comparison of related donor peripheral blood and bone marrow transplants: Importance of late-onset chronic graft-versus-host disease and infections. Biology of Blood and Marrow Transplantation, 9(1), 52-59.
    Armitage, J.O., & Antman, K.H. (Eds.). (1992). High-dose cancer therapy. Pharmacology, hematopoietins, stem cells. Baltimore: Lippincott Williams and Wilkins.
    Baldwin, P.D. (2002). Febrile nonhemolytic transfusion reactions. Clinical Journal of Oncology Nursing, 6, 171-173.
    Barnes, R.A. (1998a). Fungal infections. In J. Barrett & J.G. Treleaven (Eds.), The clinical practice of stem cell transplantation, vol.2 (pp. 723-740). St. Louis, MO: Mosby.
    Barnes, R.A. (1998b). Other infections. In J. Barrett & J.G. Treleaven (Eds.), The clinical practice of stem cell transplantation, vol.2 (pp. 741-744). St. Louis, MO: Mosby.
    Belcher, A.E. (1993). Blood disorders. St. Louis, MO: Mosby.
    Beutler, E. (1993). Platelet transfusions: The 20,000/ul trigger. Blood, 81, 1411-1413.
    Beyer, J., Schwella, N., Zingsem, J., Strohscheer, I., Schwanter, I., Oettle, H., et al. (1995). Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. Journal of Clinical Oncology, 13, 1328-1335.
    Bishop, M.R., Tarantolo, S.R., Geller, R.B., Lynch, J.C., Bierman, P.J., Pavletic, Z.S., et al. (2000). A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood, 96, 80-85.
    Bittencourt, H., Rocha, V., Chevret, S., Socie, G., Esperou, H., Devergie, A., et al. (2002). Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood, 99, 2726-2733.
    Boeckh, M., & Boivin, G. (1998). Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clinical Microbiology Review, 11, 533-554.
    BRT Laboratories. (2000). Thrombotic thrombocytopenia purpura. Retrieved November 6, 2003, from http://www.rhlab.com/Winter2000.htm
    Buchsel, P.C. (1997). Allogeneic bone marrow transplantation. In S.L. Groenwald, M.H. Frogge, M. Goodman, & C.H. Yarbro (Eds.), Cancer nursing: Principles and practice (pp. 459-506). Sudbury, MA: Jones and Bartlett.
    Centers for Disease Control and Prevention, Infectious Diseases Society of America, & American Society of Blood and Marrow Transplantation. (2000). Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biology of Blood and Marrow Transplantation, 6, 659-702.
    Chamberland, M.E. (2002). Emerging infectious agents: Do they pose a risk to the safety of transfused blood and blood products? Clinical Infectious Disease, 34, 797-805.
    Champlin, R.E., Schmitz, N., Horowitz, M.M., Chapuis, B., Chopra, R., Cornelissen, J.J., et al. (2000). Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood, 95, 3702-3709.
    de Azevedo, A.M., Nucci, M., Maiolino, A., Vigorito, A.C., Simoes, B.P., Aranha, F.J.P., et al. (2002). A randomized multicenter study of G-CSF starting on day +1 versus day +5 after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplantation, 29, 745-751.
    Deeg, H.J. (1990). Delayed complications and long term effects after bone marrow transplantation. Hematology/Oncology Clinics of North America, 4, 641-657.
    Dominietto, A., Raiola, A.M., van Lint, M.T., Lamparelli, T., Gualandi, F., Berisso, G., et al. (2001). Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: Graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. British Journal of Haematology, 112, 219-227.
    Ellerhorst-Ryan, J. (1997). Infection. In S.L. Groenwald, M.H. Frogge, M. Goodman, & C.H. Yarbro (Eds.), Cancer nursing: Principles and practice (pp. 585-603). Sudbury, MA: Jones and Bartlett.
    Ener, R.A., Meglathery, S.B., Cuhaci, B., Topolsky, D., Styler, M.J., Crilley, P., et al. (2001). Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: What is the optimal timing? American Journal of Clinical Oncology, 24, 19-25.
    Erickson, J.M. (1996). Anemia. Seminars in Oncology Nursing, 12(1), 2-14.
    Ezzone, S. (Ed.). (1997). Peripheral blood stem cell transplantation: Recommendations for nursing education and practice. Pittsburgh, PA: Oncology Nursing Society.
    Franco, T., & Gould, D.A. (1994). Allogeneic bone marrow transplant. Seminars in Oncology Nursing, 10, 3-11.
    Fuller, A.K. (1990). Platelet transfusion therapy for thrombocytopenia. Seminars in Oncology Nursing, 6, 123-128.
    George, J.N., & Rizvi, A.H. (2001). Diagnosis and management of thrombocytopenia. In R.W. Coman, J. Hirsh, V.J. Marder, A.W. Clowes, & J.N. George (Eds.), Hemostasis and thrombosis: Basic principles and clinical practice (pp. 1021-1031). Philadelphia: Lippincott Williams and Wilkins.
    George, J.N., Vesely, S.K., & Rizvi, A.H. (2001). Thrombotic thrombocytopenia purpura-hemolytic uremic syndrome. In R.W. Coman, J. Hirsh, V.J. Marder, A.W. Clowes, & J.N. George (Eds.), Hemostasis and thrombosis: Basic principles and clinical practice (pp. 1234-1242). Philadelphia: Lippincott Williams and Wilkins.
    Gillespie, T.W. (2002). Effects of cancer-related anemia on clinical and quality of life outcomes. Clinical Journal of Oncology Nursing, 6, 206-211.
    Glaspy, J.A., Jadeja, J.S., Justice, G., Kessler, J., Richards, D., Schwartzberg, L., et al. (2002). Darbepoetin alfa given every 1-2 weeks alleviates anemia associated with cancer therapy. British Journal of Cancer, 87, 268-276.
    Groenwald, S.L., Frogge, M.H., Goodman, M., & Yarbro, C.H. (Eds.). (1997). Cancer nursing: Principles and practice (4th ed.). Sudbury, MA: Jones and Bartlett.
    Groopman, J.F., & Itri, L.M. (1999). Chemotherapy-induced anemia in adults: Incidence and treatment. Journal of the National Cancer Institute, 91, 1616-1634.
    Guertler, L. (2002). Virus safety of human blood, plasma, and derived products. Thrombosis Research, 107(Suppl. 1), S39.
    Herrmann, R.P., Trent, M., Cooney, J., & Cannell, P.K. (1999). Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplantation, 24, 1213-1217.
    International Bone Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry. (2003). Report on the state of the art in blood and marrow transplantation. IBMTR/ABMTR Newsletter, 10, 1.
    Junghanss, C., & Marr, K.A. (2002). Infectious risks and outcomes after stem cell transplantation: Are nonmyeloablative transplants changing the picture? Current Opinion in Infectious Diseases, 15, 347-353.
    Kiss, J.E., Rybka, W.B., Winkelstein, A., deMagalhaes-Silverman, M., Lister, J., Andrea, P.D., et al. (1997). Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 19, 303-310.
    Klumpp, T.R., Goldberg, S.L., & Mangan, K.F. (1995). Effect of granulocyte colony-stimulating factor on the rate of neutrophil engraftment following peripheral-blood stem-cell transplantation. Journal of Clinical Oncology, 13, 935-961.
    Labovich, T.M. (1997). Transfusion therapy: Nursing implications. Clinical Journal of Oncology Nursing, 1, 61-72.
    Lee, S.J., Klar, N., Weeks, J.C., & Antin, J.H. (2000). Predicting costs of stem cell transplantation. Journal of Clinical Oncology, 18, 64-71.
    Loney, M., & Chernecky, C. (2000). Anemia. Oncology Nursing Forum, 27, 951-964.
    Lum, L.G. (1990). Immune recovery after bone marrow transplantation. Hematology/Oncology Clinics of North America, 4, 659-669.
    Marr, K.A. (2001). Antifungal prophylaxis in hematopoietic stem cell transplant recipients. Oncology, 15(11, Suppl. 9), 15-19.
    Marr, K.A., Carter, R.A., Crippa, F., Wald, A., & Corey, L. (2002). Epidemiology and outcomes of mold infections of hematopoietic stem cell transplant recipients. Clinical Infectious Diseases, 34, 909-917.
    Meisenberg, B.R., Ferran, K., Hollenbach, K., Brehm, T., Jollon, J., & Piro, L.D. (1998). Reduced charges and costs associated with outpatient autologous stem cell transplantation. Bone Marrow Transplantation, 21, 927-932.
    Moake, J.L., & Byrnes, J.J. (1996). Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematology/Oncology Clinics of North America, 10, 485-497.
    National Cancer Institute. (1999). Common toxicity criteria (version 2.0). Bethesda, MD: Author.
    Nichols, W.G., & Boeckh, M. (2000). Conference report: 2nd International Conference on Transplant Infectious Disease. Transplantation, 1, 3.
    Osarogiagbon, R.U., Defor, T.E., Weisdorf, M.A., Erice, A., & Weisdorf, D.J. (2000). CMV antigenemia following bone marrow transplantation: Risk factors and outcomes. Biology of Blood and Marrow Transplantation, 6, 280-288.
    Passweg, J.R., Rowlings, P.A., Atkinson, K.A., Barrett, A.J., Gale, R.P., Gratwohl, A., et al. (1998). Red blood cell transfusions for anemia. Seminars in Oncology Nursing, 6, 117-122.
    Pavletic, Z.S., Bishop, M.R., Tarantolo, S.R., Martin-Algarra, S., Bierman, P.J., Vose, J.M., et al. (1997). Hematopoietic recovery after allogeneic blood stem cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. Journal of Clinical Oncology, 15, 1608-1616.
    Phillips, G.L. (1999). Management of infections. In H.J. Deeg, H.G. Klingemann, G.L. Phillips, & G. Van Zant (Eds.), A guide to blood and marrow transplantation (pp. 143-158). New York: Springer.
    Pirker, R., & Smith, R. (2002). Darbepoetin alfa. Potential role in managing anemia in cancer patients. Expert Review of Anticancer Therapy, 2, 377.
    Plaza, I.L. (2000, May). A practical approach to blood component transfusion therapy. Transfusion Medicine Update. Pittsburgh, PA: Institute for Transfusion Medicine.
    Prentice, G., Grundy, J.E., & Kho, P. (1998). Cytomegalovirus. In J. Barrett & J.G. Treleaven (Eds.), The clinical practice of stem cell transplantation, vol.2 (pp. 697-707). St. Louis, MO: Mosby.
    Rieger, P.T., & Haeuber, D. (1995). A new approach to managing chemotherapy-related anemia: Nursing implications of epoetin alfa. Oncology Nursing Forum, 22, 71-81.
    Riley, U. (1998). Bacterial infections. In J. Barrett & J.G. Treleaven (Eds.), The clinical practice of stem cell transplantation, vol.2 (pp. 690-696). St. Louis, MO: Mosby.
    Rogers, B. (2002). Management of anemia in the ambulatory patient with cancer. Oncology Supportive Care Quarterly, 1(1), 19-26.
    Rowe, J.M., Ciobanu, N., Ascensao, J., Stadtmauer, E.A., Weiner, R.S., Schenkein, D.P., et al. (1994). Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. Annals of Internal Medicine, 120, 143-158.
    Russell, J.A., Chaudhry, A., Booth, K., Brown, C., Woodman, R.C., Valentine, K., et al. (2000). Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience. Biology of Blood and Marrow Transplantation, 6, 109-114.
    Rust, D.M., Wood, L.S., & Battiato, L.A. (1999). Oprelvekin. An alternative treatment for thrombocytopenia. Clinical Journal of Oncology Nursing, 3, 57-62.
    Rutherford, C.J., & Frenkel, E.P. (1994). Thrombocytopenia. Issues in diagnosis and therapy. Medical Clinics of North America, 78, 555-575.
    Shapiro, T.W., Davison, D.B., & Rust, D.M.A. (1997). Clinical guide to stem cell and bone marrow transplantation. Sudbury, MA: Jones and Bartlett.
    Shuey, K.M. (1996). Platelet-associated bleeding disorders. Seminars in Oncology Nursing, 12, 15-27.
    Shulman, K.A., Birch, R., Zhen, B., Pania, N., & Weaver, C.H. (1999). Effect of CD34+ cell dose on resource utilization in patients after high-dose chemotherapy with peripheral blood stem cell support. Journal of Clinical Oncology, 17, 1227-1233.
    Sniecinski, I.J., & O'Donnell, M.R. (1999). Hemolytic complications of hematopoietic cell transplantation. In E.D. Thomas, K.G. Blume, & S.J. Forman (Eds.), Hematopoietic cell transplantation (2nd ed., pp. 674-682). Melbourne, Australia: Blackwell Science.
    Triulzi, D.J. (2000). Leuko reduction. Transfusion medicine update. Retrieved January 13, 2004, from http://www.itxm.org/TMU200/TMU3_4-2000.htm
    Uderzo, C., Fumagalli, M., DeLorenzo, P., Busca, A., Vassallo, E., Bonanomi, S., et al. (2000). Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplantation, 26, 1005-1009.
    van Burik, J.H., & Weisdorf, D.J. (1999). Infections in recipients of blood and marrow transplantation. Hematology/Oncology Clinics of North America, 13, 1065-1089.
    Vreilink, H., & Reesink, H.W. (1998). Transfusion transmissible infections. Current Opinion in Hematology, 6, 396-405.
    Wagner, N.D., & Quinones, V.W. (1999). Allogeneic peripheral blood stem cell transplantation: Clinical overview and nursing implications. Oncology Nursing Forum, 25, 1049-1055.
    Walker, F., & Burcat, S. (1997). Hematologic effects of transplantation. In M.B. Whedon & D. Wujcik (Eds.), Blood and marrow stem cell transplantation: Principles, practice, and nursing insights (pp. 205-219). Sudbury, MA: Jones and Bartlett.
    Walker, F., Roethke, S.K., & Martin, G. (1994). An overview of the rationale, process and nursing implications of peripheral blood stem cell transplantation. Cancer Nursing, 17, 141-148.
    Westmoreland, D. (1998). Other viral infections. In J. Barrett & J.G. Treleaven (Eds.), The clinical practice of stem cell transplantation, vol.2 (pp. 709-721). St. Louis, MO: Mosby.
    Whedon, M.B., & Wujcik, D. (Eds.). (1997). Blood and marrow stem cell transplantation: Principles, practice, and nursing insights (2nd ed.). Sudbury, MA: Jones and Bartlett.